Benutzer: Gast  Login
Titel:

Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.

Dokumenttyp:
Journal Article; Article
Autor(en):
Specht, K; Harbeck, N; Smida, J; Annecke, K; Reich, U; Naehrig, J; Langer, R; Mages, J; Busch, R; Kruse, E; Klein-Hitpass, L; Schmitt, M; Kiechle, M; Hoefler, H
Abstract:
Cyclophosphamide, methotrexate and 5-fluorouracile (CMF)-based chemotherapy for adjuvant treatment of breast cancer reduces the risk of relapse. In this exploratory study, we tested the feasibility of identifying molecular markers of recurrence in CMF-treated patients. Using Affymetrix U133A GeneChips, RNA samples from 19 patients with primary breast cancer who had been uniformly treated with adjuvant CMF chemotherapy were analyzed. Two supervised class prediction approaches were used to identif...     »
Zeitschriftentitel:
Breast Cancer Res Treat
Jahr:
2009
Band / Volume:
118
Heft / Issue:
1
Seitenangaben Beitrag:
45-56
Sprache:
eng
Volltext / DOI:
doi:10.1007/s10549-008-0207-y
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18925433
Print-ISSN:
0167-6806
TUM Einrichtung:
Frauenklinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie; Institut für Medizinische Mikrobiologie, Immunologie und Hygiene; Institut für Medizinische Statistik und Epidemiologie
 BibTeX